Tourette Syndrome and Its Comorbidities

This course will define Tourette syndrome, review the diagnostic criteria and review expected comorbidities.

Target Audience

Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Clinical Pharmacists, Rehabilitation and Pain Management Specialists, as well as other specialists interested in the field of neuroscience.

Learning Objectives

  • Define the epidemiology of Tourette syndrome, and recognize core clinical features associated with this syndrome.
  • Describe optimal therapeutic options for Tourette syndrome that will minimize any complications caused by comorbidities and their relevance.
Additional information
Bibliography: 
  • Hoekstra, P. J., Steenhuis, M. P., Troost, P. W., Korf, J., Kallenberg, C. G., & Minderaa, R. B. (2004). Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioral problems in tic disorders. Journal of Developmental & Behavioral Pediatrics, 25(4), 272-279.
  • Bohlhalter, S., Goldfine, A., Matteson, S., Garraux, G., Hanakawa, T., Kansaku, K., ... & Hallett, M. (2006). Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain, 129(8), 2029-2037.
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ABIM MOC
  • 0.50 General certificate of attendance
Course opens: 
02/01/2019
Course expires: 
02/01/2022

Jorge L. Juncos, M.D.
Professor of Neurology
Emory University School of Medicine
Neurologist, Emory Clinic
Atlanta, Georgia

Jorge L. Juncos, M.D., indicated that he receives grant/research support from US World Meds, Adamas, Abbvie and Synovium, and serves as a consultant to Acadia Pharmaceuticals and Psydon. Also, Dr. Juncos is medical advisor of Tics of Georgia and the American Parkinson’s Disease Association of Georgia, and is on the advisory board of the Parkinson’s Disease Gladiators. Dr. Juncos receives research funding from the National Institutes of Health and the Michael J. Fox Foundation.

PLANNING COMMITTEE 

Kevin Abrams, M.D., indicated that he is a consultant and shareholder with Keystone Heart.

Kiwon Lee, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.

Guilherme Dabus, M.D., indicated that he is a consultant for Microvention/Terumo, Medtronic, Penumbra and Cerenovus, and on the speakers bureau for Microvention/Terumo, Medtronic and Penumbra. He is a proctor for Medtronic. Dr. Dabus is also a shareholder with Surpass Medical/Stryker, Medina/Medtronic, InNeuro Co and Three Rivers Medical. He will not include off-label or unapproved product usage in his presentation or discussion.

Daniel D’Amour, M.D., Felipe De Los Rios, M.D., Karel Fuentes, M.D., Sergio Gonzalez-Arias, M.D., Ph.D., Kunal Patel, M.S., Amy K. Starosciak, Ph.D., and Jayme Strauss, R.N., MSN, indicated that neither they nor their spouse/partner have relevant financial relationships with commercial interest companies, and they will not include off-label or unapproved product usage in their presentations or discussions.

Bruno V. Gallo, M.D., indicated that he is on speakers bureau for Teva Pharmaceuticals and Sunovion Pharmaceuticals. He receives grant support for Medtronic International, Pfizer Pharmaceuticals, Glaxo-SmithKline and St. Jude Medical, Inc. Dr. Gallo serves as a consultant for Cyberonics, Teva Pharmaceuticals, St. Jude Medical, ONS Inc. and Sugimon LLC. 

Italo Linfante, M.D., indicated that he is a consultant for Medtronic, Stryker and Penumbra. He is a stockholder with InNeuro Co.

Alberto Pinzon-Ardila, M.D., indicated that he is a member of the speakers bureau for Sunovion and UCB Pharmaceuticals.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.

NOTE: Maintenance of Certification (MOC) points will be automatically reported to the ABIM. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ABIM MOC
  • 0.50 General certificate of attendance

Accreditation Period

Course opens: 
02/01/2019
Course expires: 
02/01/2022
Please login or register to take this course.

NOTE: Maintenance of Certification (MOC) points will be automatically reported to the ABIM. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Required Hardware/software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play. 
  • Mozilla Firefox: You may be prompted under the “This Connection Is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions.”

Apple Computers Running OSX

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet
  • Safari
  • Mozilla Firefox: You may be prompted under the “This Connection Is Untrusted” screen to add “cmeonline.baptisthealth.net” and “cdn.baptisthealth.net” under “add exceptions.”

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.